Glanbia Plc · EURONEXT:GL9
Glanbia — Investor Presentation (June 2022)
29 slides from Glanbia's investor presentation, June 2022
Slide 1: Glanbia plc Investor Presentation — June 2022
a Glanbia plc Investor Presentation — June 2022 glanbia
Slide 2: Important notice
2 Glanbia plc | Overview - June 2022 Important notice This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertaint
Slide 3: Our purpose: Delivering better nutrition for every step of life's journey
3 Glanbia plc | Overview - June 2022 Our purpose: Delivering better nutrition for every step of life's journey
Slide 4: A purpose led global nutrition company
A purpose led global nutrition company Our purpose defines who we are: Providing better DELIVER for our Focused on BETTER EVERY STEP OF nutrition solutions customers, nutrition – LIFE’S JOURNEY– through specialist consumers, and supporting key from infant nutrition ingredients and stakeholders every
Slide 5: Glanbia is serving accelerating trends and societal needs
5 Glanbia plc | Overview - June 2022 Glanbia is serving accelerating trends and societal needs Health and Clean Convenience and Sustainability wellness labelling snacking and social equity $1.5tr 69% $500bn 78% Global health and of US adults say they Global health and wellness of global consumers sa
Slide 6: Our strategy is aligned with our purpose
6 Glanbia plc | Overview - June 2022 Our strategy is aligned with our purpose Ambition is to be one of the world’s top performing nutrition companies trusted to enrich lives everyday. Protect and grow our portfolio of core brands and ingredients • Growing our brands Purposeful growth • Nutritional S
Slide 7: Nutrition Focus
7 Glanbia plc | Overview - June 2022 Nutrition Focus FY 2021 Mid-term ambition Group Revenue Group EBITA €4.2bn €271m Revenue growth EBITA margin GPN 31% 54% GN - Nutritional 21% Solutions 4% to 6% 12%+ GN - US 37% 48% Cheese 9% Managed for cash and returns
Slide 8: FY 2022 Outlook
8 Glanbia plc | Overview - June 2022 FY 2022 Outlook* GPN and NS GPN and NS 80%+ Adjusted EPS Double-digit LFL** EBITA growth v PY OCF conversion Growth of 5% to revenue growth v PY 10%, CC * As updated at Q1 IMS **Like-for-like (LFL) excludes current and prior year acquisitions
Slide 9: Glanbia Performance Nutrition
Glanbia Performance Nutrition
Slide 10: Glanbia Performance Nutrition (GPN)
10 Glanbia plc | Overview - June 2022 Glanbia Performance Nutrition (GPN) Inspiring people everywhere to Acceleration of growth trends achieve their performance and healthy lifestyle goals 1.3bn Significant evolution of GPN brand portfolio 2021 € revenue Strong momentum continuing in 2022 €145m 2021
Slide 11: GPN 2019 - 2022 transformation programme
11 Glanbia plc | Overview - June 2022 GPN 2019 - 2022 transformation programme International Channel focus Key deliverables route-to-market • Portfolio focused Demand o 35%+ of SKU’s eliminated* o US private label manufacturing exited • Operations streamlined Revenue growth Brand focus o Consolidati
Slide 12: GPN Revenue - FY 2021
12 Glanbia plc | Overview - June 2022 GPN Revenue - FY 2021 By Region By Format By Channel 5% 13% 33% 13% 31% 67% 15% 22% 67% 34% Americas International Powders RTE RTD Other Online FDMC Distributor Speciality +11% +27% +23% 0% +10% +26% +11% +6% +65% +17% GPN LFL growth FY 2021 vs. FY 2020
Slide 13: Brand Focus
13 Glanbia plc | Overview - June 2022 Brand Focus Q1 2022 % GPN LFL Revenue US Revenue Growth (cc) Consumption* Brand Strategy • Drive awareness, consideration and recruitment through PROVEN creative campaign 51.3% +23.0% +15.8% • Expand distribution across markets & channels • Innovation across Dai
Slide 14: Glanbia Nutritionals
Glanbia Nutritionals
Slide 15: Glanbia Nutritionals (GN)
15 Glanbia plc | Overview - June 2022 Glanbia Nutritionals (GN) 2021 Revenue 2021 EBITA €2.9bn €126m Nutritional 30% Health, wellness and nutrition trends driving end Solutions market growth 81% US Cheese 70% Deep nutritional expertise in innovative platforms 19% Global presence in protein solutions
Slide 16: Key trends enabling GN growth
16 Glanbia plc | Overview - June 2022 Key trends enabling GN growth Trend Shortening of Dairy On the go Clean Growing New brand consumption product populations & growth convenience label expected to lifecycles urbanisation double by 2050 GN Opportunity Quality, natural Applications ingredients suppo
Slide 17: GN Operating Model
17 Glanbia plc | Overview - June 2022 GN Operating Model Deep nutritional expertise One face to Fuelled by the customer top talent Insights led Scalable Centres of Efficient, excellence Agile
Slide 18: GN Capabilities
18 Glanbia plc | Overview - June 2022 GN Capabilities Protein Custom solutions Flavours nutrient premixes Plant nutrition Micronutrient straights Film & Glitter Bioactives Aseptic beverage US Cheese manufacturing Sports & Infant Lifestyle nutrition nutrition Supplements Clinical nutrition Mainstream
Slide 19: Nutritional Solutions
19 Glanbia plc | Overview - June 2022 Nutritional Solutions Supplying growth Adding to our core technologies Leading positions markets through acquisitions Flavours Year over Year Bioactives volume growth 5 year average volume growth +7.4% CORE SOLUTIONS Micro-nutrients Protein Healthy Dairy & Plant
Slide 20: ESG
glanbia
Slide 21: Deep focus on delivering our ESG goals
21 Glanbia plc | Overview - June 2022 Deep focus on delivering our ESG goals Commitment to decarbonisation Environmental and Science Based Targets Carbon Water Waste Procurement Committed to SBTi Baseline complete and Target of 50% food waste Suppliers subject to carbon emissions target setting bein
Slide 22: Deep focus on delivering our ESG goals
22 Glanbia plc | Overview - June 2022 Deep focus on delivering our ESG goals Social Governance Diversity, Equity & Inclusion Governance • ERGs established for female, multicultural and • Board ESG committee established LGBTQ+ employees • Ongoing Board ESG training • Female management representation
Slide 23: Glanbia – Positioned For Growth
23 Glanbia plc | Overview - June 2022 Glanbia – Positioned For Growth Delivering better nutrition for every step of life's journey
Slide 24: Appendix
Appendix
Slide 25: Financial Data
25 Glanbia plc | Overview - June 2022 Financial Data Adjusted EPS Year over Year growth* (reported currency) (constant currency) 10 year CAGR +6.5% 10 year average growth (cc) +8.2% *growth presented on a constant currency basis and adjusted for Glanbia Ireland related divestments (continuing operat
Slide 26: Financial Data
26 Glanbia plc | Overview - June 2022 Financial Data Dividend policy updated in 2017 to target a pay-out ratio of 25-35% Dividend per Share & Dividend Pay-out Ratio
Slide 27: Financial Data
27 Glanbia plc | Overview - June 2022 Financial Data 2017 – 2021 5 Year Operating Cash Flow: €1.4bn 5 Year Avg. OCF Conversion %: 91.4% M&A Strategic Capex Returns to shareholders €655m €259m €458m Strategic acquisitions Returns include dividends enhancing GPN and NS Investment for future growth in
Slide 28: Notes
28 Glanbia plc | Overview - June 2022 Notes
Slide 29: Notes
29 Glanbia plc | Overview - June 2022 Notes